J&J ETFs to Shine Vibrant as FDA Grants EUA for Coronavirus Vaccine

HomeETFs

J&J ETFs to Shine Vibrant as FDA Grants EUA for Coronavirus Vaccine

The world will now obtain the primary single-shot vaccine within the battle in opposition to the coronavirus pandemic because the FDA has awarded the Emergency Use Authorization (EUA) to COVID-19 vaccine that has been developed by the Janssen Pharmaceutical Corporations of Johnson & Johnson JNJ. www.nasdaq.com



The world will now obtain the primary single-shot vaccine within the battle in opposition to the coronavirus pandemic because the FDA has awarded the Emergency Use Authorization (EUA) to COVID-19 vaccine that has been developed by the Janssen Pharmaceutical Corporations of Johnson & Johnson JNJ.



www.nasdaq.com